Screener
PTC Therapeutics PTCT Income Tax
Income Tax at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by PTC Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The source filing: PTC Therapeutics’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:32 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001070081-26-000012
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Interest expense, net | (49,030) | (34,092) |
| Other income (expense), net | 1,609 | (6,305) |
| (Loss) income before income tax expense | (2,462) | 929,828 |
| Income tax expense | (347) | (63,266) |
| Net (loss) income attributable to common stockholders | $(2,809) | $866,562 |
| Weighted-average shares outstanding: | ||
| Basic (in shares) | 82,521,023 | 78,115,836 |
| Diluted (in shares) | 82,521,023 | 86,385,922 |
Item 1. Financial Statements (unaudited)
FAQ
- What is PTC Therapeutics's income tax?
- PTC Therapeutics (PTCT) reported income tax of $347K in Q1 2026.
- How has PTC Therapeutics's income tax changed year-over-year?
- PTC Therapeutics's income tax decreased by 99.5% year-over-year, from $63.27M to $347K.
- What is the long-term trend for PTC Therapeutics's income tax?
- Over 2 years (2021 to 2023), PTC Therapeutics's income tax has grown at a 253.6% compound annual growth rate (CAGR), from $5.56M to -$69.51M.
- What does income tax mean?
- Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.
Ask your AI about PTC Therapeutics's income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude